- Home
- ANIX vs RMMZ Comparison
ANIX vs RMMZ Comparison
Compare ANIX & RMMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANIX | RMMZ |
|---|---|---|
| Founded | 1982 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.3M | 123.9M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANIX | RMMZ |
|---|---|---|
| Price | $3.59 | $14.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 353.5K | 25.6K |
| Earning Date | 01-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.07 | $12.92 |
| 52 Week High | $5.46 | $16.99 |
Technical Indicators
Market Signals| Indicator | ANIX | RMMZ |
|---|---|---|
| Relative Strength Index (RSI) | 36.66 | 52.88 |
| Support Level | $4.20 | $14.67 |
| Resistance Level | $5.46 | $15.12 |
| Average True Range (ATR) | 0.42 | 0.18 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 3.40 | 65.54 |
Price Performance
Historical ComparisonAbout ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About RMMZ RiverNorth Managed Duration Municipal Income Fund II Inc.
RiverNorth Managed Duration Municipal Income Fund II Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.